Psilocybin-Assisted Therapy for Veterans With PTSD
Open-label Phase 2 trial of psilocybin-assisted therapy in U.S. military veterans with PTSD. Underway now — closed to new enrollment; results pending.
This study is already underway and closed to new participants. It's listed here so you can see the research happening in the field right now.
This is an interventional study — the research team administers the treatment under a controlled, IRB-approved protocol. Participation never happens outside that protocol.
- Substance
- Psilocybin
- Status
- In progress
- Conditions
- PTSD
- Who can join
- U.S. military veterans (21–64) with PTSD
- Where
- Columbus, OH
- Run by
- Ohio State University (A. Davis)
- Registry ID
- NCT05554094 ↗
How to join this study
The sponsor has not published a contact for this study. The official registry page is the only way in — it is updated by the research team and may list a contact later.
Open the study on ClinicalTrials.gov →What taking part involves
Participants will receive two doses of psilocybin, approximately 2 weeks apart, in conjunction with preparatory and post-psilocybin therapy sessions
You enroll directly with the research team through their own official page and IRB-approved consent process. Psychedelic Vets does not run this study or collect any of your health information.
Study data is sourced from ClinicalTrials.gov (U.S. National Library of Medicine) and verified university/nonprofit sources. This page is educational and is not medical advice or an endorsement. Details can change — always confirm on the official page above. ← Back to all studies